AGTR1 and myocardial infarction: Since both no-reflow and adverse left ventricular remodeling negatively influence clinical outcomes after myocardial infarction (14, 15), we undertook the present study to analyze the prognostic role of AT1R-AAs and ETAR-AAs in patients with STEMI treated with PPCI.